Public Comments to Agencies | Citizens Against Government Waste

Public Comments to Agencies

Agency Comments

Comment to FDA on Draft Guidance for Importation of Certain Drugs

Citizens Against Government Waste's Comment on Draft Guidance: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products

Elizabeth Wright February 21, 2020
Agency Comments

CAGW Submits Comments to FCC on 5.850-5.925 GHz Band Usage

CAGW offers comments supporting the FCC's NPRM to expand and enhance the use of the 5.850 – 5.925 GHz spectrum band.

Peter Klensch February 21, 2020
Agency Comments

Comment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)

Medicaid is a federal and state funded program but is administered by the states.

Elizabeth Wright January 31, 2020
Agency Comments

CAGW Submits Comments to CMS on Transparency Rule

CAGW has long advocated for more market forces to be used in the U.S. healthcare system. 

Elizabeth Wright January 28, 2020
Agency Comments

Coalition Comments on Biosimilar and Interchangeable Insulin Guidance

CAGW and coalition partners share the FDA's deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.

Peter Klensch January 28, 2020
Agency Comments

Coalition Urges Significant Changes to Proposed Commerce Rule

Coalition of taxpayer and consumer advocacy groups urges signficant changes to proposed Commerce rule that would grant broad, undefined powers to the deparment over small businesses.

Peter Klensch January 10, 2020
Agency Comments

CAGW Submits Comments to Bureau of Consumer Financial Protection on Payday Lending Rule

May 14, 2019 The Honorable Kathy Kraninger Director Bureau of Consumer Financial Protection 1700 G Street, NW Washington, D.C., 20552 Dear Director Kraninger:

Allen Johnson May 14, 2019
Agency Comments

CAGW Submits Comments to FDA on Biological Product INNs

April 30, 2019  Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Docket No. FDA-2013-D-1543 Nonproprietary Naming of Biological Products: Update; Draft Guidance for Industry;...

member (not verified) April 30, 2019
Agency Comments

Coalition Comments to FCC on KidVid Regulations

March 26, 2019 VIA ELECTRONIC SUBMISSION Marlene H. Dortch Secretary Federal Communications Commission 44512th Street, SW Washington, DC 20554

member (not verified) March 29, 2019
Agency Comments

CAGW Joins Coalition to Support FHFA Rule on Alternative Credit Score Models

March 21, 2019 Alfred M. Pollard, General Counsel Federal Housing Finance Agency 400 Seventh St. NW, 8th Floor Washington, DC 20219 Attention: Comments/ RIN 2590-AA98: Validation and Approval of Credit Score Models by Fannie Mae and Freddie Mac

member (not verified) March 22, 2019
Agency Comments

CAGW: FDA Should Embrace Harm Reduction, Approve Modified Risk Tobacco Product Application

January 8, 2019 Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852   Re: U.S. Smokeless Tobacco Company, LLC. MRTP Application for Copenhagen Snuff Docket FDA-2018-N-3261  

Spencer Chretien January 8, 2019
Agency Comments

CAGW Submits Comments to the Federal Trade Commission on Competition and Consumer Protection in the 21st Century relating to innovation and intellectual property rights

December 21, 2018 Federal Trade Commission 600 Pennsylvania Avenue, N.W. Washington, D.C.  20580   Ref: Docket ID: FTC-2018-0090 Dear Commissioners,

Deborah Collier December 21, 2018

Pages

Sign Up For Email Updates


Optional Member Code